Sai-Ching Jim Yeung Selected Research

Hyperglycemia

10/2012	A randomized controlled trial of an intensive insulin regimen in patients with hyperglycemic acute lymphoblastic leukemia.
6/2012	Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sai-Ching Jim Yeung Research Topics

Disease

36	Neoplasms (Cancer) 10/2022 - 03/2002
7	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2010
4	Esophageal Squamous Cell Carcinoma 10/2022 - 01/2020
4	Infections 01/2022 - 06/2017
4	Sepsis (Septicemia) 08/2021 - 12/2016
3	Carcinoma (Carcinomatosis) 01/2022 - 01/2017
3	Pain (Aches) 08/2021 - 01/2019
3	Neoplasm Metastasis (Metastasis) 01/2020 - 04/2015
3	Anaplastic Thyroid Carcinoma 03/2006 - 02/2003
2	Cardiotoxicity 01/2022 - 01/2017
2	Insulin Resistance 01/2021 - 01/2011
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 02/2010
2	Pulmonary Embolism 07/2019 - 12/2017
2	Posterior Leukoencephalopathy Syndrome 11/2018 - 01/2017
2	Inflammation (Inflammations) 01/2017 - 07/2014
2	Carcinogenesis 07/2014 - 10/2005
2	Hyperglycemia 10/2012 - 06/2012
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2012 - 06/2012
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2011 - 07/2009
2	Ovarian Neoplasms (Ovarian Cancer) 10/2003 - 03/2002
1	Dysbiosis 02/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Cysts 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Cachexia 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021
1	Lung Neoplasms (Lung Cancer) 10/2020
1	Adenocarcinoma of Lung 01/2020
1	Esophageal Neoplasms (Esophageal Cancer) 01/2020
1	Cancer Pain 01/2020

Drug/Important Bio-Agent (IBA)

7	Metformin (Glucophage)FDA LinkGeneric 08/2021 - 04/2011
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2015
6	manumycinIBA 10/2008 - 03/2002
6	Farnesyltranstransferase (Farnesyltransferase)IBA 10/2008 - 02/2003
5	Antineoplastic Agents (Antineoplastics)IBA 01/2017 - 03/2002
5	Proteins (Proteins, Gene)FDA Link 04/2015 - 10/2003
4	Immune Checkpoint InhibitorsIBA 02/2022 - 01/2020
4	Anti-Bacterial Agents (Antibiotics)IBA 02/2022 - 12/2016
4	Glucose (Dextrose)FDA LinkGeneric 10/2012 - 07/2009
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 02/2003
3	Everolimus FDA Link 01/2021 - 07/2014
3	Insulin (Novolin)FDA Link 01/2021 - 04/2011
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021 - 04/2011
3	MicroRNAs (MicroRNA)IBA 06/2017 - 12/2016
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 04/2011
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 10/2012
2	Epirubicin (Ellence)FDA LinkGeneric 01/2022 - 01/2017
2	B7-H1 AntigenIBA 01/2022 - 01/2019
2	AnthracyclinesIBA 01/2022 - 06/2012
2	Trastuzumab (Herceptin)FDA Link 01/2022 - 12/2019
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
2	Lactic Acid (Lactate)FDA LinkGeneric 08/2021 - 01/2021
2	Nicotine FDA Link 08/2021 - 01/2021
2	Dextromethorphan (Racemethorphan)FDA LinkGeneric 08/2021 - 01/2021
2	Rosiglitazone (Avandia)FDA Link 01/2021 - 04/2011
2	Opioid Analgesics (Opioids)IBA 01/2020 - 01/2019
2	fibrin fragment D (D-dimer)IBA 07/2019 - 01/2019
2	Biological ProductsIBA 01/2017 - 07/2014
2	Phosphotransferases (Kinase)IBA 04/2015 - 02/2010
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2012 - 01/2011
2	Exenatide (Byetta)FDA Link 04/2011 - 01/2011
2	Aurora Kinase BIBA 02/2010 - 12/2008
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2006 - 05/2005
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	Docetaxel (Taxotere)FDA Link 01/2022
1	Transfer RNA (tRNA)IBA 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	ProcalcitoninIBA 08/2021
1	C-Reactive ProteinIBA 08/2021
1	Analgesics (Analgesic Drugs)IBA 08/2021
1	human ERBB2 proteinIBA 01/2021
1	Cystine (L-Cystine)IBA 01/2021
1	Cysteine (L-Cysteine)FDA Link 01/2021
1	Pyruvic Acid (Pyruvate)IBA 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	mouse Chrna7 proteinIBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Amino Acids FDA Link 01/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	Leptin ReceptorsIBA 01/2021
1	Coal (Coals)IBA 10/2020
1	fu-yuanIBA 10/2020
1	Caspase 3 (Caspase-3)IBA 01/2020
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2020
1	Circulating Tumor DNAIBA 01/2020
1	Hydromorphone (Dilaudid)FDA LinkGeneric 01/2020

Therapy/Procedure

12	Therapeutics 01/2021 - 03/2002
10	Drug Therapy (Chemotherapy) 10/2022 - 12/2008
7	Immunotherapy 02/2022 - 01/2017
2	Lymph Node Excision (Lymph Node Dissection) 10/2022 - 04/2015
2	Neoadjuvant Therapy 01/2022 - 01/2022
2	Intravenous Infusions 01/2017 - 01/2011
1	Length of Stay 01/2022
1	Hospice Care (Care, Bereavement) 01/2022
1	Palliative Care (Palliative Therapy) 01/2022
1	Patient Readmission 08/2021
1	Parenteral Nutrition 01/2021
1	Enteral Nutrition (Feeding, Tube) 01/2021